ReviewBiomedicines2026
From Gut Homeostasis to Colorectal Cancer: Spatial and Temporal Reprogramming of Microbial Inosine Signaling.
Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhancing Targeted Colorectal Cancer Therapies with Natural Products: Mechanistic Pathways.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Microbial metabolites are increasingly recognized as critical regulators of gut homeostasis, mediating the interaction among gut microbiota, host tissue, and immune response. Among them, inosine, which was previously considered just a byproduct of the adenosine catabolism, was recently discovered as an important bioactive purine metabolite with distinctive context-dependent signaling function. Indeed, inosine supports intestinal barrier integrity and modulates the immune response under physiological conditions. However, this scenario completely changes when chronic inflammation, dysbiosis, and colorectal cancer (CRC) develop, leading to a profound alteration of its spatial distribution and biological function. This review summarizes the biochemical properties, signaling, and sources of inosine and its role in the maintenance of gut homeostasis. We will also discuss the dynamic regulation of host-microbiota interaction, driven by inosine during CRC development and its progression following its spatial redistribution and temporal reprogramming. In particular, we will describe how inosine can shift from a tumor-supportive role to a trigger of anti-tumor immunity by promoting T cell function and macrophage polarization, becoming a critical modulator of host-microbiota crosstalk in health and disease and a promising therapeutic target for microbiome-based strategies and combined clinical approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.